Hester Biosciences Ltd Quarterly Results

Gross Sales

70.97

84.11

81.93

63.22

83.69

Excise Duty

0

0

0

0

0

Net Sales

70.97

84.11

81.93

63.22

83.69

Other Operating Income

0

0

0

0

0

Other Income

11.88

3.37

-5.64

8.78

2.8

Total Income

82.85

87.47

76.29

72

86.49

Total Expenditure

59.25

61.29

62.74

58.16

64.53

PBIDT

23.6

26.18

13.54

13.85

21.96

Interest

2.21

1.81

5.62

-3.81

5.89

PBDT

21.39

24.37

7.92

17.66

16.07

Depreciation

4.35

4.18

4.18

4.29

4.2

Minority Interest Before NP

0

0

0

0

0

Tax

2.57

2.16

4.11

1.65

3.38

Deferred Tax

0.14

0.74

-1.91

0.31

0.1

Reported Profit After Tax

14.33

17.3

1.54

11.41

8.39

Minority Interest After NP

-0.12

0.85

0.25

-0.25

0.19

Net Profit after Minority Interest

14.45

16.44

1.29

11.66

8.2

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

14.45

16.44

1.29

11.66

8.2

EPS (Unit Curr.)

16.85

20.33

1.82

13.41

9.86

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

33.25

31.12

16.52

21.9

26.23

PBDTM(%)

30.13

28.97

9.66

27.93

19.2

PATM(%)

20.19

20.56

1.87

18.04

10.02